[ad_1]
An Israeli pharmaceutical company has announced that it will begin studies on the drug’s effectiveness next month. first oral vaccine against coronavirus.
It would be a pill that it does not require cold storage or administration by a healthcare professional.
Héctor Roizin, physician member of the executive and treasurer of the Israeli Society of Ambulatory Pediatrics, explained to Channel 3 the main advantages of this inoculation format.
/ Home Integration code /
Also look
Fight against the coronavirus
/ Complete the embed code /
“The vaccine generates three types of immunity (mucous membranes, blood and cells) which are not offered by the intramuscular vaccine, ”he stressed.
However, the expert acknowledged that “for now the level of effectiveness is unknown”. “What has been seen is that, as far as Pfizer and Moderna are concerned, it offers the same level of immunity,” he said.
Roizin pointed out that the greatest strength is that “an oral vaccine produces great ease of administration”.
The vaccine would be administered in two doses.
Agustina Vivanco report.
.
[ad_2]
Source link